Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 266

1.

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis.

Niyazi M, Adeberg S, Kaul D, Boulesteix AL, Bougatf N, Fleischmann DF, Grün A, Krämer A, Rödel C, Eckert F, Paulsen F, Kessel KA, Combs SE, Oehlke O, Grosu AL, Seidlitz A, Lattermann A, Krause M, Baumann M, Guberina M, Stuschke M, Budach V, Belka C, Debus J.

Radiother Oncol. 2018 Feb 9. pii: S0167-8140(18)30033-1. doi: 10.1016/j.radonc.2018.01.011. [Epub ahead of print]

PMID:
29433917
2.

[Nivolumab for pretreated metastatic anal cancer : Immune checkpoint blockade is also advised in combination with radiochemotherapy].

Martin D, Rödel C, Fokas E.

Strahlenther Onkol. 2018 Feb 1. doi: 10.1007/s00066-018-1272-8. [Epub ahead of print] German. No abstract available.

PMID:
29392353
3.

Development and validation of a gene signature for patients with head and neck squamous cell carcinomas treated by postoperative radio(chemo)therapy.

Schmidt S, Linge A, Zwanenburg A, Leger S, Lohaus F, Krenn C, Appold S, Gudziol V, Nowak A, von Neubeck C, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch SU, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Baumann M, Krause M, Löck S.

Clin Cancer Res. 2018 Jan 3. pii: clincanres.2345.2017. doi: 10.1158/1078-0432.CCR-17-2345. [Epub ahead of print]

PMID:
29298797
4.

Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.

Linge A, Schötz U, Löck S, Lohaus F, Neubeck CV, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M; DKTK-ROG.

Radiother Oncol. 2017 Dec 30. pii: S0167-8140(17)32762-7. doi: 10.1016/j.radonc.2017.12.007. [Epub ahead of print]

PMID:
29295747
5.

Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Stangl S, Tontcheva N, Sievert W, Shevtsov M, Niu M, Schmid TE, Pigorsch S, Combs SE, Haller B, Balermpas P, Rödel F, Rödel C, Fokas E, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Stuschke M, Grosu AL, Abdollahi A, Debus J, Belka C, Maihöfer C, Mönnich D, Zips D, Multhoff G.

Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31213. [Epub ahead of print]

PMID:
29235112
6.

S3-Leitlinie – Kolorektales Karzinom.

Schmiegel W, Buchberger B, Follmann M, Graeven U, Heinemann V, Langer T, Nothacker M, Porschen R, Rödel C, Rösch T, Schmitt W, Wesselmann S, Pox C.

Z Gastroenterol. 2017 Dec;55(12):1344-1498. doi: 10.1055/s-0043-121106. Epub 2017 Dec 6. German. No abstract available.

PMID:
29212104
Free Article
7.

Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.

Fokas E, Ströbel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, Kaufmann M, Sauer R, Graeven U, Hoffmanns H, Raab HR, Hothorn T, Wittekind C, Rödel C; German Rectal Cancer Study Group.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx095.

PMID:
29206996
8.

Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.

Rödel F, Steinhäuser K, Kreis NN, Friemel A, Martin D, Wieland U, Rave-Fränk M, Balermpas P, Fokas E, Louwen F, Rödel C, Yuan J.

Radiother Oncol. 2017 Nov 6. pii: S0167-8140(17)32679-8. doi: 10.1016/j.radonc.2017.10.028. [Epub ahead of print]

PMID:
29122359
9.

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer.

Martin D, Rödel F, Winkelmann R, Balermpas P, Rödel C, Fokas E.

Front Immunol. 2017 Sep 29;8:1225. doi: 10.3389/fimmu.2017.01225. eCollection 2017.

10.

SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.

De-Colle C, Menegakis A, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, Tinhofer I, Budach V, Abu Jawad J, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Belka C, Ganswindt U, Pigorsch S, Combs SE, Lohaus F, Linge A, Krause M, Baumann M, Zips D; DKTK-ROG.

Radiother Oncol. 2018 Jan;126(1):125-131. doi: 10.1016/j.radonc.2017.10.008. Epub 2017 Oct 20.

PMID:
29061496
11.

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling.

Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Krause M, Baumann M, Troost EGC, Löck S, Richter C.

Sci Rep. 2017 Oct 16;7(1):13206. doi: 10.1038/s41598-017-13448-3.

12.

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee.

Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40. doi: 10.1093/annonc/mdx224. No abstract available.

PMID:
28881920
13.

Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.

Stera S, Balermpas P, Chan MKH, Huttenlocher S, Wurster S, Keller C, Imhoff D, Rades D, Dunst J, Rödel C, Hildebrandt G, Blanck O.

Strahlenther Onkol. 2018 Feb;194(2):143-155. doi: 10.1007/s00066-017-1204-z. Epub 2017 Sep 5.

PMID:
28875297
14.

Efficient laser-driven proton acceleration from cylindrical and planar cryogenic hydrogen jets.

Obst L, Göde S, Rehwald M, Brack FE, Branco J, Bock S, Bussmann M, Cowan TE, Curry CB, Fiuza F, Gauthier M, Gebhardt R, Helbig U, Huebl A, Hübner U, Irman A, Kazak L, Kim JB, Kluge T, Kraft S, Loeser M, Metzkes J, Mishra R, Rödel C, Schlenvoigt HP, Siebold M, Tiggesbäumker J, Wolter S, Ziegler T, Schramm U, Glenzer SH, Zeil K.

Sci Rep. 2017 Aug 31;7(1):10248. doi: 10.1038/s41598-017-10589-3.

15.

Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.

Jiang P, Krockenberger K, Vonthein R, Tereszczuk J, Schreiber A, Liebau S, Huttenlocher S, Imhoff D, Balermpas P, Keller C, Dellas K, Baumann R, Rödel C, Hildebrandt G, Jünemann KP, Merseburger AS, Katz A, Ziegler A, Blanck O, Dunst J.

Radiat Oncol. 2017 Aug 18;12(1):138. doi: 10.1186/s13014-017-0872-2.

16.

[Optimal fractionation regimen, and time between radiotherapy and operation in rectal cancer : The multicenter, randomized Stockholm III trial].

Fokas E, Rödel C.

Strahlenther Onkol. 2017 Sep;193(9):761-762. doi: 10.1007/s00066-017-1181-2. German. No abstract available.

PMID:
28698903
17.

High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : A systematic review.

Chatzikonstantinou G, Zamboglou N, Rödel C, Zoga E, Strouthos I, Butt SA, Tselis N.

Strahlenther Onkol. 2017 Sep;193(9):683-691. doi: 10.1007/s00066-017-1157-2. Epub 2017 Jun 16. Review.

PMID:
28623436
18.

A clinical example of extreme dose exposure for an implanted cardioverter-defibrillator : Beyond the DEGRO guidelines.

Hristova Y, Köhn J, Preuß S, Rödel C, Balermpas P.

Strahlenther Onkol. 2017 Sep;193(9):756-760. doi: 10.1007/s00066-017-1152-7. Epub 2017 May 31.

PMID:
28567504
19.

Relativistic Electron Streaming Instabilities Modulate Proton Beams Accelerated in Laser-Plasma Interactions.

Göde S, Rödel C, Zeil K, Mishra R, Gauthier M, Brack FE, Kluge T, MacDonald MJ, Metzkes J, Obst L, Rehwald M, Ruyer C, Schlenvoigt HP, Schumaker W, Sommer P, Cowan TE, Schramm U, Glenzer S, Fiuza F.

Phys Rev Lett. 2017 May 12;118(19):194801. doi: 10.1103/PhysRevLett.118.194801. Epub 2017 May 11.

PMID:
28548516
20.

Erratum to: Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters.

Yildirim M, Müller von der Grün J, Winkelmann R, Fokas E, Rödel F, Ackermann H, Rödel C, Balermpas P.

Strahlenther Onkol. 2017 Aug;193(8):682. doi: 10.1007/s00066-017-1155-4. No abstract available.

PMID:
28540428

Supplemental Content

Loading ...
Support Center